No profile data available.
Bio-Rad Laboratories, Inc. (BIO) is a healthcare company in the additional medical testing equipment industry, based in Hercules, United States, with about 7,450 full-time employees.
It reported revenue of $2.58 billion for fiscal year 2025, up 0.7% from fiscal year 2024, and net income of $759.90 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $651.00 million, down 0.1% from a year before. Its largest business segment, Clinical Diagnostics, brought in 60% of segment revenue in fiscal year 2025; United States was the largest region with 40%. Its market capitalization was $9.80 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics.
Bio-Rad Laboratories reported $2.58 billion in revenue for fiscal year 2025, up 0.7% from $2.57 billion in fiscal year 2024. In Q2 2026 revenue was $651.00 million.
Clinical Diagnostics, with $1.56 billion or 60% of segment revenue in fiscal year 2025. Next: Life Science (40%).
United States: 40% of revenue by region in fiscal year 2025, followed by Europe (34%).
$9.80 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (additional medical testing equipment) include QuidelOrtho Corporation (QDEL), Exagen Inc. (XGN), Global Cord Blood Corporation (CORBF), Biomerica, Inc. (BMRA).